3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
27
Carcinoma, Hepatocellular
24
Small Cell Lung Carcinoma
18
Lung Neoplasms
15
Neoplasms
13
Breast Neoplasms
9
Colorectal Neoplasms
7
Carcinoma, Renal Cell
7
Squamous Cell Carcinoma of Head and Neck
6
Melanoma
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Prostatic Neoplasms
5
Neoplasm Metastasis
5
Carcinoma, Transitional Cell
5
Sarcoma
4
Glioblastoma
4
Stomach Neoplasms
3
Solid Tumors
3
Sarcoma, Alveolar Soft Part
3
Ovarian Neoplasms
3
Mesothelioma, Malignant
3
Liver Neoplasms
3
Extensive Stage Lung Small Cell Carcinoma
3
Endometrial Neoplasms
3
Carcinoma, Neuroendocrine
3
Carcinoma
3
Treatment-Refractory Solid Tumors
2
Small Cell Lung Cancer Extensive Stage
2
Interventions
pembrolizumab
53
Paclitaxel
20
Cisplatin
15
Carboplatin
15
lenvatinib
10
Docetaxel
9
Saline Solution
7
Capecitabine
7
Pemetrexed
6
Oxaliplatin
6
Gemcitabine
6
Fluorouracil
6
Leucovorin
5
Albumin-Bound Paclitaxel
5
olaparib
4
belzutifan
4
Bevacizumab
4
130-nm albumin-bound paclitaxel
4
patritumab deruxtecan
3
Glucose
3
Acetaminophen
3
liposomal doxorubicin
2
Levoleucovorin
2
Irinotecan
2
Histamine H2 Antagonists
2
Histamine Antagonists
2
Etoposide
2
Doxorubicin
2
Dexamethasone
2
Cetuximab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
atezolizumab
×
90 days
×
Clear all
No trials found.